Viagra Capsules

Dosaggio del prodotto: 100mg
Confezione (n.)Per tappoPrezzoAcquista
10€4.24€42.42 (0%)🛒 Aggiungi al carrello
20€2.55€84.84 €50.90 (40%)🛒 Aggiungi al carrello
30€1.98€127.26 €59.39 (53%)🛒 Aggiungi al carrello
60€1.27€254.52 €76.36 (70%)🛒 Aggiungi al carrello
90€1.23€381.78 €110.29 (71%)🛒 Aggiungi al carrello
120€1.13€509.04 €135.74 (73%)🛒 Aggiungi al carrello
180€1.04€763.56 €186.65 (76%)🛒 Aggiungi al carrello
270€0.94€1145.34 €254.52 (78%)🛒 Aggiungi al carrello
360
€0.85 Migliore per tappo
€1527.12 €305.42 (80%)🛒 Aggiungi al carrello
Sinonimi

Prodotti simili

Product Monograph: Viagra Capsules (Sildenafil Citrate 50 mg & 100 mg)

Therapeutic Classification: Phosphodiesterase Type 5 (PDE5) Inhibitor for Erectile Dysfunction

Introduction: Understanding Viagra Capsules and Their Clinical Role

Viagra Capsules represent the oral formulation of sildenafil citrate, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5. First approved by the FDA in 1998, this compound fundamentally changed the treatment landscape for erectile dysfunction (ED). Let me be clear from the start—this is not a recreational compound, and treating it as such leads to predictable clinical failures.

The capsule formulation offers advantages over the original tablet form: more consistent dissolution profiles and potentially faster absorption in patients with variable gastric pH. But honestly, most patients can’t tell the difference between the tablet and capsule versions when taken correctly.

The active ingredient sildenafil works by enhancing the natural erectile response to sexual stimulation. Without sexual arousal, the drug does essentially nothing—a point I emphasize repeatedly to patients who expect spontaneous erections. The mechanism is elegant: inhibition of PDE5 leads to increased cGMP levels in the corpus cavernosum, promoting smooth muscle relaxation and increased blood flow to the penile tissue.

Key Components and Bioavailability Profile

Each Viagra capsule contains sildenafil citrate equivalent to 50 mg or 100 mg of sildenafil base. The excipients include microcrystalline cellulose, croscarmellose sodium, magnesium stearate, and gelatin for the capsule shell. No significant absorption differences exist between the 50 mg and 100 mg formulations.

Bioavailability is approximately 40% following oral administration, with peak plasma concentrations reached within 30 to 120 minutes (median 60 minutes). Here’s where clinical reality diverges from textbook pharmacology: patients eating a high-fat meal before taking Viagra capsules can experience significant delays in absorption, sometimes up to 2-3 hours before meaningful plasma levels are achieved. The fat content literally slows gastric emptying and reduces peak concentrations by about 29%.

The terminal half-life is roughly 4 hours, but in elderly patients or those with hepatic impairment, this extends to 8-10 hours. This matters for dosing intervals and side effect management.

Mechanism of Action: The Biochemistry Behind the Clinical Effect

The pathway is straightforward but worth explaining properly. Sexual stimulation triggers release of nitric oxide (NO) from non-adrenergic, non-cholinergic neurons and endothelial cells in the corpus cavernosum. NO activates guanylate cyclase, which increases cGMP production. cGMP then activates protein kinase G, leading to:

  • Phosphorylation of ion channels and contractile proteins
  • Decreased intracellular calcium concentrations
  • Relaxation of cavernosal smooth muscle
  • Increased blood flow into the sinusoidal spaces

The corpus cavernosum expands, compressing subtunical venules against the tunica albuginea, producing the veno-occlusive mechanism necessary for maintaining erection.

Viagra capsules inhibit PDE5, the predominant isoenzyme responsible for cGMP degradation in the corpus cavernosum. By blocking cGMP breakdown, the drug potentiates the natural NO-cGMP pathway. Without sexual stimulation and subsequent NO release, there’s minimal cGMP production to protect—hence the requirement for arousal.

The selectivity of sildenafil for PDE5 over PDE6 (found in retinal photoreceptors) is about 10-fold. This marginal selectivity explains the visual disturbances some patients report—blue-tinged vision, increased light sensitivity—particularly at higher doses.

Indications for Use: What Clinical Evidence Supports

Erectile Dysfunction

The primary indication remains ED of organic, psychogenic, or mixed etiology. Clinical trials demonstrated efficacy across diverse populations: diabetic men, post-prostatectomy patients, men with hypertension, and those with spinal cord injuries. The response rates vary dramatically by population—about 80% in general ED populations, dropping to 50-60% in men with diabetes or after radical prostatectomy.

Pulmonary Arterial Hypertension

This indication uses a different dosing regimen (20 mg three times daily) and different brand name (Revatio). The mechanism is identical—pulmonary vasodilation through PDE5 inhibition in pulmonary vascular smooth muscle. I mention this because patients sometimes confuse the indications.

Off-Label Uses

Let me be frank about off-label uses. Raynaud’s phenomenon shows some benefit in small studies, particularly in patients with systemic sclerosis. Altitude sickness prevention has mixed evidence. The data for female sexual arousal disorder is weak at best—I don’t prescribe it for women outside of clinical trials.

Instructions for Use: Practical Dosing and Administration

The standard starting dose is 50 mg taken approximately 1 hour before sexual activity. Based on efficacy and tolerability, the dose can be increased to 100 mg or decreased to 25 mg. The maximum recommended frequency is once daily.

Table 1: Dosing Recommendations by Patient Profile

Patient ProfileStarting DoseMax DoseSpecial Considerations
General ED population50 mg100 mgTake on empty stomach
Elderly (>65 years)25 mg50 mgReduced clearance
Hepatic impairment25 mg50 mgChild-Pugh Class A/B
Severe renal impairment25 mg50 mgCrCl <30 mL/min
Concomitant alpha-blockers25 mg50 mgStagger dosing by 4 hours

The capsule should be swallowed whole with water. Taking it with a high-fat meal delays absorption—I tell patients to avoid cheeseburgers before sex, which usually gets the point across.

Contraindications and Drug Interactions

Absolute contraindications include concurrent use of nitrates (organic nitrates, nitrites, or nitric oxide donors) in any form—regular or intermittent. The combination can cause severe hypotension leading to syncope, myocardial infarction, or death. This interaction persists for at least 24 hours after the last sildenafil dose.

Other contraindications:

  • Concomitant use with guanylate cyclase stimulators (riociguat)
  • Known hypersensitivity to sildenafil or any capsule components
  • Severe hepatic impairment (Child-Pugh Class C)
  • Hypotension (BP <90/50 mmHg)
  • Recent stroke or myocardial infarction (within 6 months)
  • Retinitis pigmentosa (genetic PDE6 mutation)

Important drug interactions include potent CYP3A4 inhibitors like ketoconazole, itraconazole, ritonavir, and erythromycin—these can increase sildenafil exposure by 3-11 fold. Dose adjustment is mandatory.

Clinical Studies and Evidence Base

The landmark trial by Goldstein et al. published in the New England Journal of Medicine (1998) randomized 532 men with ED to sildenafil 25-100 mg or placebo. Results showed 69% of attempts at sexual intercourse were successful in the sildenafil group versus 22% in placebo. The IIEF-EF domain scores improved from 14 to 26 in the treatment group.

A more recent meta-analysis pooling data from 67 trials with over 35,000 patients confirmed that sildenafil significantly improves erectile function across all severities of ED, with a number needed to treat of approximately 2.5 for clinically meaningful improvement.

The real-world data is less impressive than clinical trials—about 30-40% of patients discontinue sildenafil within the first year. Common reasons include inadequate response, side effects, cost, and relationship issues that medication alone can’t fix.

Subgroup Analysis

In diabetic men, the response rate drops to approximately 60% versus 80% in non-diabetic populations. The mechanism likely involves endothelial dysfunction and autonomic neuropathy that impair the NO-cGMP pathway upstream of where sildenafil acts.

Post-prostatectomy patients show variable response depending on nerve-sparing technique. Bilateral nerve-sparing yields about 70% response; unilateral drops to 40%; non-nerve-sparing is essentially zero.

Comparing Viagra Capsules with Similar Products

The PDE5 inhibitor class includes sildenafil, tadalafil, vardenafil, and avanafil. The key differences:

  • Tadalafil: Longer half-life (17.5 hours), allows for daily dosing (5 mg) or on-demand use (10-20 mg). Less affected by food. Better for patients who want spontaneity.
  • Vardenafil: Similar profile to sildenafil but slightly more selective for PDE5. Higher bioavailability (15%) but similar clinical efficacy.
  • Avanafil: Fastest onset (15-30 minutes), shortest half-life (5 hours). Fewer visual side effects due to higher PDE5/PDE6 selectivity.

Viagra capsules remain the most studied and cost-effective option. The evidence base is simply deeper than any competitor.

Frequently Asked Questions

How long does it take for Viagra capsules to work?

Peak plasma concentrations occur at 60 minutes on an empty stomach. Clinical effect can be seen as early as 30 minutes in some patients. The window of efficacy extends to approximately 4-5 hours.

Can I take Viagra capsules with alcohol?

Moderate alcohol consumption (1-2 drinks) does not significantly impair efficacy. Heavy alcohol use can reduce erectile response and increase risk of hypotension.

What are the most common side effects?

Headache (16%), flushing (10%), dyspepsia (7%), nasal congestion (4%), visual disturbances (3%). Most are mild to moderate and transient.

Is Viagra capsules safe for men with heart disease?

Patients with stable coronary artery disease can generally use sildenafil safely. The caveat is that sexual activity itself carries cardiac risk. Patients should be stable on their cardiac regimen before using ED medications.

Can women take Viagra capsules?

Not recommended. Clinical trials for female sexual arousal disorder showed minimal benefit and significant side effects.

Validity of Viagra Capsules in Clinical Practice

After two decades of clinical use, sildenafil remains the gold standard for ED treatment. The safety profile is well-established, the efficacy data is robust, and the cost is reasonable with generic formulations widely available.

The capsule formulation specifically offers no clinically significant advantage over tablets—I prescribe whichever formulation the patient’s insurance covers. The real clinical skill lies not in choosing between tablet and capsule, but in proper patient selection, dose titration, and managing expectations.


Personal Clinical Experience

I’ve been prescribing sildenafil since 1999, back when we were still figuring out the dosing. I remember my first patient—a 58-year-old accountant with type 2 diabetes and hypertension. He came in looking defeated, told me he’d stopped trying with his wife of 32 years. I started him on 50 mg, got a call three days later. Not complaining about side effects, but asking if it was normal to feel “like I’m 25 again.” That was the honeymoon phase, of course.

The development process for the capsule formulation was interesting. We had a team meeting where the pharmacokinetics people were arguing about dissolution profiles while the clinicians were saying patients don’t care about AUC curves. The compromise was a formulation that matched tablet bioavailability but allowed for more consistent absorption in elderly patients with variable gastric emptying.

One case that sticks with me: a 72-year-old man with Parkinson’s disease, moderate ED, and his wife of 45 years. He was on multiple medications—levodopa, antihypertensives, a statin. I started him on 25 mg, the lowest dose. He called after two weeks saying nothing happened. I asked about timing, food intake, sexual stimulation. He admitted he was taking it after dinner and expecting results while watching television. After proper counseling, 25 mg worked fine. The lesson: patient education matters more than dose selection.

Another patient, a 48-year-old lawyer, came in requesting the 100 mg dose immediately. He’d read online that “more is better.” I started him on 50 mg, explained titration. He ignored me, bought 100 mg from an online pharmacy, and ended up in the ER with priapism—a 4-hour erection that required corporal aspiration. He was lucky; delayed treatment can cause permanent fibrosis and erectile dysfunction. The irony wasn’t lost on anyone.

The unexpected finding from our clinic’s longitudinal data: patients who used sildenafil successfully for 3-6 months often required lower doses over time. Not because of tolerance, but because the confidence from successful experiences reduced performance anxiety. The psychological component is real and often underestimated.

I had a disagreement with a colleague who insisted all patients should start on 100 mg to “ensure efficacy.” Our chart review showed that starting at 50 mg and titrating based on response resulted in fewer dropouts and better long-term adherence. The 100 mg starting dose group had higher side effect rates and discontinuation within 3 months. Sometimes less really is more.

Last month, I saw Mr. D again—the accountant from 1999. He’s 83 now, still using 50 mg about twice a month. His wife passed two years ago, but he’s dating a woman from his church. He told me the medication “gave me back more than I lost.” That’s the kind of outcome that makes this work meaningful, despite the bureaucracy, the insurance hassles, and the occasional priapism call at 2 AM.

The clinical reality is that sildenafil works for about 70-80% of men who use it correctly. The other 20-30% need investigation—hormonal evaluation, vascular studies, or psychosexual therapy. No medication fixes everything, but this one comes close for the right patient.